Skip to content

Insider · CIK 0001726398

Jonathan David Schwartz

officer

Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing May 20, 2025, latest Nov 20, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $64k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RCKT: ROCKET PHARMACEUTICALS, INC.

RCKTOct 9, 2026 · close 2.56

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
RCKTsell 4
ROCKET PHARMACEUTICALS, INC.
$7,592
2,545 shares
-1%+26% from low-80% from high
30Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$7,561
2,485 shares
-1%+30% from low-86% from high
36Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$34k
11,161 shares
-5%+30% from low-86% from high
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$5,163
801 shares
-0%+43% from low-69% from high
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$10k
1,582 shares
-1%+36% from low-70% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-2,545$2.98$7,592299,064Nov 20, 2025
Sep 8, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+80,000$0.00$0301,609Sep 9, 2025
Aug 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,680$3.07$5,149222,414Aug 20, 2025
Aug 19, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-805$3.00$2,412221,609Aug 20, 2025
Aug 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-11,161$3.02$34k224,094Aug 18, 2025
May 20, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-801$6.45$5,163235,255May 22, 2025
May 16, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,582$6.53$10k236,056May 20, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jonathan David Schwartz: insider trades and track record | InsiderTell